Neuroscience Global Market Report 2025

Neuroscience, delving into the intricacies of the human nervous system and brain, integrates cellular and molecular biology, anatomy, physiology, human behavior, cognition, and related fields to comprehensively map brain functionalities. Its applications extend to the development of pharmaceuticals, treatments, and preventive methodologies for various health conditions, offering solutions to a spectrum of health concerns.

Diverse branches within neuroscience encompass neuro-microscopy, electrophysiology technologies, neuro-cellular manipulation, whole brain imaging, and other specialized tools provided through instruments, consumables, software, and services. Neuro-microscopy, tailored for surgeries involving the brain, spinal cord, and spine, serves as an operating microscope. It facilitates illumination and magnification of deeper surgical fields, equipped with features like a binocular head with adjustable eyepieces and foot controls, ensuring enhanced precision and maneuverability. The application of neuroscience spans across hospitals, diagnostic labs, research facilities, and academic institutes, supporting various scientific endeavors and medical advancements.

The neuroscience market research report is one of a series of new reports from The Business Research Company that provides neuroscience market statistics, including neuroscience industry global market size, regional shares, competitors with a neuroscience market share, detailed neuroscience market segments, market trends and opportunities, and any further data you may need to thrive in the neuroscience industry. This neuroscience market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuroscience market size has grown strongly in recent years. It will grow from $35.51 billion in 2024 to $37.58 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increased funding for neuroscience research, emergence of neuroinformatic, genomic and proteomic research in neuroscience, public awareness and education, drug discovery and development, global aging population, neuroscience-based education and learning.

The neuroscience market size is expected to see strong growth in the next few years. It will grow to $50.69 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to precision medicine in neurological treatments, expansion of neuropharmacology, neuroinformatic for big data management, patient-centric approaches in neurological care, global health initiatives for neurological disorders, innovations in neurological diagnostics, ethical considerations, and guidelines. Major trends in the forecast period include brain imaging technologies, neurostimulation therapies, artificial intelligence in neuroscience, brain-computer interface (BCI) technology, telemedicine in neurology, collaboration between industry and academia, cross-disciplinary approaches.

The increasing geriatric population is expected to boost the neuroscience market. Individuals aged 65 years and older are classified as part of the geriatric population. Due to reduced immunity and advancing age, this group is more vulnerable to various diseases, including neurological disorders. Common neurological conditions affecting older adults include lumbar arthrosis and dementia, both of which can be addressed through neuroscience. For example, a report by the United Nations, a US-based diplomatic and political international organization, stated in July 2022 that the global population aged 65 and older is projected to rise from 10% in 2022 to 16% by 2050, indicating a significant increase in this age group worldwide by mid-century. Therefore, the growing geriatric population is a key driver of the neuroscience market.

The rising incidence of neurological disorders, particularly Alzheimer's disease, is expected to drive growth in the neuroscience market. Neurological disorders encompass a wide range of medical conditions that primarily impact the nervous system, including the brain, spinal cord, and peripheral nerves. Alzheimer's disease is a progressive neurodegenerative disorder that significantly affects cognitive function and memory. Neuroscience plays a crucial role in understanding and treating Alzheimer's disease; by examining the structure and function of the nervous system, neuroscientists are uncovering the underlying causes of AD and developing new approaches for diagnosis, prevention, and treatment. For instance, a report by the Alzheimer's Association, a U.S.-based nonprofit organization focused on Alzheimer's care, support, and research, revealed in May 2024 that the number of Americans aged 65 and older diagnosed with Alzheimer's dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the rising incidence of neurological disorders, such as Alzheimer's disease, is a significant driver of the neuroscience market.

Technological advancement is a significant trend gaining traction in the neuroscience market. Leading companies are focusing on developing innovative technologies such as artificial intelligence (AI) and machine learning to enhance neuroscience. AI allows machines to replicate and even exceed human cognitive abilities, with machine learning being a subset of AI. AI models are designed to perform intelligence-driven tasks, offering new insights into how similar processes are regulated within the brain. For example, in February 2024, Koninklijke Philips N.V., a Netherlands-based technology firm, partnered with Synthetic MR, a Sweden-based MRI software company, to launch Smart Quant Neuro 3D. This groundbreaking tool is designed for diagnosing and assessing brain disorders such as multiple sclerosis, traumatic brain injury, and dementia. The solution combines Philips' AI-powered SmartSpeed technology, the 3D SyntAc application, and Synthetic MR's SyMRI NEURO 3D software, providing healthcare providers with enhanced diagnostic capabilities to improve confidence and patient outcomes. Philips has exclusive rights to offer SyMRI NEURO 3D on its MR scanners.

Major companies operating in the neuroscience sector are concentrating on launching innovative products, such as brain implant technology, to maintain their competitive edge in the market. Brain implant technology involves devices that are directly inserted into the brain to interact with neural tissue, facilitating the stimulation, monitoring, or modulation of brain activity. For example, in October 2022, Axoft, a health technology company based in the U.S., introduced a groundbreaking brain implant technology designed for the treatment of long-term neurological disorders, which received FDA Breakthrough Device Designation. Their innovative gliosis-free implants can safely remain in the central nervous system over the long term, providing electrical stability and an ultra-high density of sensors for improved brain-electronics communication. Axoft's minimally invasive implants offer high-bandwidth, stable single-neuron measurements and can adapt to changes in the brain, ensuring long-term functionality without the need for frequent replacements, making them particularly suitable for brain-machine interfaces (BMI).

In March 2022, AbbVie, a biopharmaceutical company based in the United States, completed the acquisition of Syndesi Therapeutics SA for an undisclosed sum. AbbVie's objective behind this acquisition was to bolster its neuroscience portfolio by gaining access to Syndesi's range of advanced SV2A modulators, notably their flagship drug SDI-118. Syndesi Therapeutics SA, headquartered in Belgium, specializes in drug discovery within the field of neurology within the biotechnology sector.

Major companies operating in the neuroscience market are Alpha Omega Inc., General Electric Company, Siemens Healthineers AG, NeuroNexus Technologies Inc., Doric Lenses Inc., Blackrock Neurotech, Axion Biosystems Inc., Femtonics Ltd., Carl Zeiss AG, Danaher Corporation (Leica Microsystems), Koninklijke Philips N.V., Toshiba Corporation, Hitachi Medical Corporation, Scientifica Ltd., Intan Technologies Inc., Laserglow Technologies Inc., Mightex Systems, Neuralink Corporation, Kernel Corporation, BrainCo Inc., MindMaze Inc., Paradromics Inc., NeuroPro Inc., NeuroSky Inc., EMOTIV Inc., Cercare Medical A/S, Plexon Inc., Noldus Information Technology bv, Neuralynx Inc., Vigil Neuroscience

North America was the largest region in the neuroscience market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroscience market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neuroscience market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neuroscience market consists of the revenues earned by consulting services, installation services, and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuroscience Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuroscience market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuroscience ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neuroscience market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Neuro-Microscopy; Electrophysiology Technologies; Neuro-Cellular Manipulation; Whole Brain Imaging; Other Types
• 2) By Service: Instruments And Consumables; Software And Services
• 3) By End User: Hospitals; Diagnostic Labs; Research And Academic Institutes
• Subsegments:
• 1) By Neuro-Microscopy: Two-Photon Microscopy; Confocal Microscopy; Super-Resolution Microscopy
• 2) By Electrophysiology Technologies: Patch Clamp Systems; Multi-Electrode Arrays (MEAs); Intracellular And Extracellular Recorders
• 3) By Neuro-Cellular Manipulation: Optogenetics Tools; Microinjection Systems; Electroporation Devices
• 4) By Whole Brain Imaging: Functional Magnetic Resonance Imaging (fMRI); Positron Emission Tomography (PET); Diffusion Tensor Imaging (DTI)
• 5) By Other Types: Neuroinformatics Tools; Brain-Computer Interface Technologies; Neuromodulation Devices
• Companies Mentioned: Alpha Omega Inc.; General Electric Company; Siemens Healthineers AG; NeuroNexus Technologies Inc.; Doric Lenses Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.